Company / EPS (Diluted)
Insulet Corporation EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$2.94
FY2025
5-year range
$0.07 / $2.94
FY2021-FY2025
Trend
+4100.0%
vs FY2024
Sector context
#47 of 159
Health Care
What the data says
EPS (Diluted) changed +4100% YoY in FY2025, a notable deviation from the 9-year average annual change of +483%.
Based on SEC 10-K filings.
2.94 in FY2025 with a 5-year CAGR of +125.9%.
Improved from $0.24 to $2.94 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +208.6%
- 5-Year CAGR
- +125.9%
- 10-Year CAGR
- -
Sector benchmark
#47 of 159 in Health CareTop 30% of 159This company $2.94 Sector average $1.64
▼
+79.4% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 4100.0% year-over-year.
- Ranks #47 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.94 | +4100.0% |
| FY2024 | $0.07 | -70.8% |
| FY2023 | $0.24 | +140.0% |
| FY2022 | $0.10 | -47.4% |
| FY2021 | $0.19 | +280.0% |
| FY2020 | $0.05 | +110.9% |
| FY2019 | -$0.46 | +4.2% |
| FY2018 | -$0.48 | -182.4% |
| FY2017 | -$0.17 | +10.5% |
| FY2016 | -$0.19 | +77.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026